Lucida Medical raises £507k

Lucida Medical, a healthtech company based in Cambridge, issued 970 new shares at £523.00 each on 9 September, according to its Companies House filing. That adds up to £507k of new capital. At that share price, the indicative valuation after the round is about £27.9m. Investors have not been named in the filing yet.

✓ Verified · official record, 3 Nov 2026. What this means

How we work this out: the amount is the number of new shares multiplied by the price paid for each one, as reported on the SH01 filing. The valuation is that price multiplied by every share in issue afterwards. It's indicative only: it ignores options and convertible notes, some rounds are filed in more than one tranche, and companies can hide it. Methodology